Sensitive ASX Announcement

aVb6 Integrin (RAD301) IND approval for Phase 1 trial

Published: 30/12/22, 09:58am (AEST)2 pages
Radiopharm Theranostics Limited
RAD:ASXHealthcare

Recent RAD Announcements

Price Sensitive only